Description
Sequel offers an innovative benefit program aimed at empowering employers to improve their diabetes management strategies by focusing on complex, high-cost members who require insulin therapy. Developed by Sequel Med Tech, the program features the twiist Automated Insulin Delivery System, which is provided directly to members. This approach sets a new standard for diabetes benefits, promoting both enhanced management and potential medical cost savings.
Additional Details
Lives Served
-
Company Size
235
Year Founded
2023
Funding
550M
Contact Details
Website URL
Gallery
No images found!
Video
No url found!
There are no reviews yet.